Found: 47
Select item for more details and to access through your institution.
PIN-like ductal carcinoma of the prostate has frequent activating RAS/RAF mutations.
- Published in:
- Histopathology, 2021, v. 78, p. 327, doi. 10.1111/his.14224
- By:
- Publication type:
- Article
PIN‐like ductal carcinoma of the prostate has frequent activating RAS/RAF mutations.
- Published in:
- Histopathology, 2021, v. 78, n. 1, p. 327, doi. 10.1111/his.14224
- By:
- Publication type:
- Article
TRIUMPH: phase II trial of rucaparib monotherapy in patients with metastatic hormone-sensitive prostate cancer harboring germline homologous recombination repair gene mutations.
- Published in:
- Oncologist, 2024, v. 29, n. 9, p. 794, doi. 10.1093/oncolo/oyae120
- By:
- Publication type:
- Article
Large Cell Neuroendocrine Prostate Cancer: Large Is Not Small.
- Published in:
- Oncologist, 2024, v. 29, n. 3, p. 185, doi. 10.1093/oncolo/oyad344
- By:
- Publication type:
- Article
Tumor Frameshift Mutation Proportion Predicts Response to Immunotherapy in Mismatch Repair‐Deficient Prostate Cancer.
- Published in:
- Oncologist, 2021, v. 26, n. 2, p. e270, doi. 10.1002/onco.13601
- By:
- Publication type:
- Article
Pan‐Cancer Analysis of CDK12 Loss‐of‐Function Alterations and Their Association with the Focal Tandem‐Duplicator Phenotype.
- Published in:
- Oncologist, 2019, v. 24, n. 12, p. 1526, doi. 10.1634/theoncologist.2019-0214
- By:
- Publication type:
- Article
Genomic and clinical characterization of stromal infiltration markers in prostate cancer.
- Published in:
- 2020
- By:
- Publication type:
- journal article
An immunohistochemical signature comprising PTEN, MYC, and Ki67 predicts progression in prostate cancer patients receiving adjuvant docetaxel after prostatectomy.
- Published in:
- Cancer (0008543X), 2012, v. 118, n. 24, p. 6063, doi. 10.1002/cncr.27689
- By:
- Publication type:
- Article
Botulinum toxin type A inhibits sensory neuropeptide release in rat bladder models of acute injury and chronic inflammation.
- Published in:
- BJU International, 2008, v. 101, n. 3, p. 366, doi. 10.1111/j.1464-410X.2007.07312.x
- By:
- Publication type:
- Article
An mTORC1-mediated negative feedback loop constrains amino acid-induced FLCN-Rag activation in renal cells with TSC2 loss.
- Published in:
- Nature Communications, 2022, v. 13, n. 1, p. 1, doi. 10.1038/s41467-022-34617-7
- By:
- Publication type:
- Article
Gene expression signatures of neuroendocrine prostate cancer and primary small cell prostatic carcinoma.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Localization of macrophage subtypes and neutrophils in the prostate tumor microenvironment and their association with prostate cancer racial disparities.
- Published in:
- Prostate, 2022, v. 82, n. 16, p. 1505, doi. 10.1002/pros.24424
- By:
- Publication type:
- Article
Clinical and genomic features of SPOP‐mutant prostate cancer.
- Published in:
- Prostate, 2022, v. 82, n. 2, p. 260, doi. 10.1002/pros.24269
- By:
- Publication type:
- Article
Neuroendocrine differentiation in usual‐type prostatic adenocarcinoma: Molecular characterization and clinical significance.
- Published in:
- Prostate, 2020, v. 80, n. 12, p. 1012, doi. 10.1002/pros.24035
- By:
- Publication type:
- Article
Germline BLM mutations and metastatic prostate cancer.
- Published in:
- Prostate, 2020, v. 80, n. 2, p. 235, doi. 10.1002/pros.23924
- By:
- Publication type:
- Article
Genomic and clinical characterization of pulmonary‐only metastatic prostate cancer: A unique molecular subtype.
- Published in:
- Prostate, 2019, v. 79, n. 13, p. 1572, doi. 10.1002/pros.23881
- By:
- Publication type:
- Article
ETS2 is a prostate basal cell marker and is highly expressed in prostate cancers aberrantly expressing p63.
- Published in:
- Prostate, 2018, v. 78, n. 12, p. 896, doi. 10.1002/pros.23646
- By:
- Publication type:
- Article
Intraductal/ductal histology and lymphovascular invasion are associated with germline DNA‐repair gene mutations in prostate cancer.
- Published in:
- Prostate, 2018, v. 78, n. 5, p. 401, doi. 10.1002/pros.23484
- By:
- Publication type:
- Article
Multidisciplinary Intervention of Early, Lethal Metastatic Prostate Cancer: Report From the 2015 Coffey-Holden Prostate Cancer Academy Meeting.
- Published in:
- Prostate, 2016, v. 76, n. 2, p. 125, doi. 10.1002/pros.23107
- By:
- Publication type:
- Article
PTEN loss and ERG protein expression are infrequent in prostatic ductal adenocarcinomas and concurrent acinar carcinomas.
- Published in:
- Prostate, 2015, v. 75, n. 14, p. 1610, doi. 10.1002/pros.23042
- By:
- Publication type:
- Article
Renal epithelioid angiomyolipomas overexpress TFE3 and the TFE3-regulated gene TRIM63 in the absence of TFE3 rearrangement.
- Published in:
- Virchows Archiv: European Journal of Pathology, 2024, v. 485, n. 3, p. 471, doi. 10.1007/s00428-024-03855-z
- By:
- Publication type:
- Article
DNA damage repair alterations are frequent in prostatic adenocarcinomas with focal pleomorphic giant‐cell features.
- Published in:
- Histopathology, 2019, v. 74, n. 6, p. 836, doi. 10.1111/his.13806
- By:
- Publication type:
- Article
Plasma cells are enriched in localized prostate cancer in Black men and are associated with improved outcomes.
- Published in:
- Nature Communications, 2021, v. 12, n. 1, p. 1, doi. 10.1038/s41467-021-21245-w
- By:
- Publication type:
- Article
A novel prostate cancer subtyping classifier based on luminal and basal phenotypes.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 14, p. 2169, doi. 10.1002/cncr.34790
- By:
- Publication type:
- Article
Association of B7‐H3 expression with racial ancestry, immune cell density, and androgen receptor activation in prostate cancer.
- Published in:
- Cancer (0008543X), 2022, v. 128, n. 12, p. 2269, doi. 10.1002/cncr.34190
- By:
- Publication type:
- Article
GPNMB expression identifies TSC1/2/mTOR‐associated and MiT family translocation‐driven renal neoplasms.
- Published in:
- Journal of Pathology, 2022, v. 257, n. 2, p. 158, doi. 10.1002/path.5875
- By:
- Publication type:
- Article
P2X4 purinergic receptors offer a therapeutic target for aggressive prostate cancer.
- Published in:
- Journal of Pathology, 2022, v. 256, n. 2, p. 149, doi. 10.1002/path.5815
- By:
- Publication type:
- Article
Reciprocal YAP1 loss and INSM1 expression in neuroendocrine prostate cancer.
- Published in:
- Journal of Pathology, 2021, v. 255, n. 4, p. 425, doi. 10.1002/path.5781
- By:
- Publication type:
- Article
Differential mast cell phenotypes in benign versus cancer tissues and prostate cancer oncologic outcomes.
- Published in:
- Journal of Pathology, 2021, v. 253, n. 4, p. 415, doi. 10.1002/path.5606
- By:
- Publication type:
- Article
Intraductal carcinoma of the prostate in the absence of high‐grade invasive carcinoma represents a molecularly distinct type of in situ carcinoma enriched with oncogenic driver mutations.
- Published in:
- Journal of Pathology, 2019, v. 249, n. 1, p. 79, doi. 10.1002/path.5283
- By:
- Publication type:
- Article
Molecular evidence that invasive adenocarcinoma can mimic prostatic intraepithelial neoplasia ( PIN) and intraductal carcinoma through retrograde glandular colonization.
- Published in:
- Journal of Pathology, 2016, v. 238, n. 1, p. 31, doi. 10.1002/path.4628
- By:
- Publication type:
- Article
Molekularpathologie bei urologischen Tumoren: Empfehlungen der Konsenskonferenz der Internationalen Gesellschaft für Uropathologie (ISUP) 2019.
- Published in:
- Der Pathologe, 2021, v. 42, n. 3, p. 310, doi. 10.1007/s00292-020-00888-4
- By:
- Publication type:
- Article
Mismatch repair-deficient prostate cancer with parenchymal brain metastases treated with immune checkpoint blockade.
- Published in:
- Cold Spring Harbor Molecular Case Studies, 2021, v. 7, n. 4, p. 1, doi. 10.1101/mcs.a006094
- By:
- Publication type:
- Article
The prostate tissue‐based telomere biomarker as a prognostic tool for metastasis and death from prostate cancer after prostatectomy.
- Published in:
- Journal of Pathology: Clinical Research, 2022, v. 8, n. 5, p. 481, doi. 10.1002/cjp2.288
- By:
- Publication type:
- Article
A distinct repertoire of cancer‐associated fibroblasts is enriched in cribriform prostate cancer.
- Published in:
- Journal of Pathology: Clinical Research, 2021, v. 7, n. 3, p. 271, doi. 10.1002/cjp2.205
- By:
- Publication type:
- Article
Extent, impact, and mitigation of batch effects in tumor biomarker studies using tissue microarrays.
- Published in:
- eLife, 2022, p. 1, doi. 10.7554/eLife.71265
- By:
- Publication type:
- Article
Immunomodulatory response to neoadjuvant nivolumab in non-metastatic clear cell renal cell carcinoma.
- Published in:
- Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-51889-9
- By:
- Publication type:
- Article
Immunomodulatory response to neoadjuvant nivolumab in non-metastatic clear cell renal cell carcinoma.
- Published in:
- Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-51889-9
- By:
- Publication type:
- Article
AIM1 is an actin-binding protein that suppresses cell migration and micrometastatic dissemination.
- Published in:
- Nature Communications, 2017, v. 8, n. 7, p. 1, doi. 10.1038/s41467-017-00084-8
- By:
- Publication type:
- Article
MYC Overexpression Induces Prostatic Intraepithelial Neoplasia and Loss of Nkx3.1 in Mouse Luminal Epithelial Cells.
- Published in:
- PLoS ONE, 2010, v. 5, n. 2, p. 1, doi. 10.1371/journal.pone.0009427
- By:
- Publication type:
- Article
A phase II study of the dual mTOR inhibitor MLN0128 in patients with metastatic castration resistant prostate cancer.
- Published in:
- Investigational New Drugs, 2018, v. 36, n. 3, p. 458, doi. 10.1007/s10637-018-0578-9
- By:
- Publication type:
- Article
Risk Stratification of Prostate Cancer Through Quantitative Assessment of PTEN Loss (qPTEN).
- Published in:
- 2020
- By:
- Publication type:
- journal article
Stem cell dynamics and cellular heterogeneity across lineage subtypes of castrate-resistant prostate cancer.
- Published in:
- Stem Cells, 2024, v. 42, n. 6, p. 526, doi. 10.1093/stmcls/sxae025
- By:
- Publication type:
- Article
mTORC1 feedback to AKT modulates lysosomal biogenesis through MiT/TFE regulation.
- Published in:
- 2019
- By:
- Publication type:
- journal article
mTORC1 loss impairs epidermal adhesion via TGF-β/Rho kinase activation.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Characterization of transcriptomic signature of primary prostate cancer analogous to prostatic small cell neuroendocrine carcinoma.
- Published in:
- International Journal of Cancer, 2019, v. 145, n. 12, p. 3453, doi. 10.1002/ijc.32430
- By:
- Publication type:
- Article
Effect of Preanalytic Variables on an Automated PTEN Immunohistochemistry Assay for Prostate Cancer.
- Published in:
- Archives of Pathology & Laboratory Medicine, 2019, v. 143, n. 3, p. 338, doi. 10.5858/arpa.2018-0068-OA
- By:
- Publication type:
- Article